DeepMed Research

CryJ2-LAMP-vax

Generic Name: CryJ2-LAMP-vax

Clinical Trials

A Dose-finding Study of ASP4070

Phase 2

Completed

Conditions: Rhinitis, Allergic, Seasonal

Interventions: Drug: ASP4070
Drug: Placebo

First Posted Date: 2017-04-05

Last Posted Date: 2024-11-26

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 150

Registration Number: NCT03101267

Locations: 🇯🇵
Site JP00001, Shinjuku, Tokyo, Japan

A Study of ASP4070 to Confirm Safety and Immunological Response in Patients With Pollen Allergy

Phase 1

Completed

Conditions: Cedar Pollinosis

Interventions: Drug: ASP4070
Drug: Placebo

First Posted Date: 2015-06-11

Last Posted Date: 2024-10-31

Lead Sponsor: Astellas Pharma Inc

Target Recruit Count: 66

Registration Number: NCT02469688

Prev
1
Next

Drug Development Updates

Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy